Substance Withdrawal Management Without Medical Care

Understanding Why Some Withdrawals Are Dangerous

The CNS depressants (alcohol, benzodiazepines, barbiturates) work by enhancing GABA activity — the primary inhibitory neurotransmitter in the brain. With chronic use, the brain downregulates its natural GABA response and upregulates excitatory NMDA glutamate activity to compensate.

When the depressant is removed abruptly, this excitatory upregulation has nothing to suppress it. The result is CNS hyperexcitability — manifesting as tremors, anxiety, sweating, elevated vital signs, and in severe cases, seizures and delirium.

Opioids work through a completely different mechanism (opioid receptors, not GABA), so opioid withdrawal is not associated with seizure risk in the same way.

Alcohol Withdrawal

Timeline

6-12 hours: Tremors, anxiety, diaphoresis (sweating), elevated heart rate and blood pressure, nausea and vomiting, insomnia

24-72 hours: Peak severity for most symptoms. Seizure risk is highest in this window. Approximately 25% of untreated severe alcohol withdrawal patients experience seizures.

72-96 hours: Delirium tremens (DTs) onset if going to occur. Characterized by global confusion, hallucinations (typically visual — seeing insects or small animals), autonomic instability (very high fever, heart rate, blood pressure), and agitation.

Mortality without treatment: DTs carry a 5-15% mortality rate without treatment, approaching 35% in some studies before modern intensive care.

CIWA-Ar Assessment (Clinical Institute Withdrawal Assessment)

The CIWA-Ar provides a standardized severity score. Simplified field version — score 0-7 for each:

Items assessed:

1. Nausea/vomiting: 0 (none) to 7 (constant nausea, frequent vomiting)
2. Tremor: 0 (none) to 7 (severe, even at rest)
3. Diaphoresis (sweating): 0 to 7
4. Anxiety: 0 (none) to 7 (acute panic)
5. Agitation: 0 to 7
6. Perceptual disturbances (tactile, auditory, visual): 0 to 7
7. Headache: 0 to 7
8. Orientation: 0 (fully oriented) to 4 (disoriented to time, place, person)

Interpretation:

• Score under 8: Mild withdrawal — monitor, comfort measures
• Score 8-15: Moderate — benzodiazepine indicated
• Score above 15: Severe — benzodiazepine required, close monitoring, evacuation if possible

Field Management

Benzodiazepines are the treatment. The goal is to prevent seizures and manage the CNS hyperexcitability.

Diazepam (Valium): 5-10mg orally every 6 hours, titrate to control symptoms (reduce heart rate below 100, reduce agitation to manageable). Typical total first 24-hour dose: 30-80mg depending on severity.

Lorazepam (Ativan): 1-2mg orally every 6-8 hours. More suitable for patients with liver disease (shorter half-life).

If neither is available: Phenobarbital has similar mechanism and is sometimes more accessible. Or, as a last resort: a controlled alcohol taper (see below).

Supportive care:

• Thiamine (Vitamin B1): 100mg daily minimum. Alcohol withdrawal causes thiamine deficiency, which can progress to Wernicke's encephalopathy (brain damage) and Korsakoff's syndrome. If thiamine is available, give it. If not, ensure adequate nutrition.
• Aggressive oral hydration: 2-3 liters per day
• Electrolyte replacement: vomiting + sweating depletes sodium, potassium, magnesium. Sports drinks or ORS can supplement.
• Fever management: ibuprofen or acetaminophen for fever
• Quiet, low-stimulation environment: bright light and loud noise worsen agitation

Alcohol taper (last resort when no medications available):

• Calculate the patient's typical daily intake
• Provide a divided daily dose equivalent (e.g., if they drink 12 beers per day, start with 8 beers on day 1)
• Reduce by 10-20% per day
• The goal is preventing seizures, not comfortable withdrawal
• This maintains physiological dependence and will require repeated tapering — a temporary bridge until medical care is available

Danger Signs Requiring Immediate Response

• Any seizure: administer diazepam 10mg orally or IM if available, position on side
• Temperature above 40°C / 104°F
• Hallucinations (seeing/hearing/feeling things that are not there)
• Extreme agitation or confusion
• Heart rate above 140 sustained
• Blood pressure above 180 systolic

Opioid Withdrawal

Timeline

Short-acting opioids (heroin, oxycodone, hydrocodone): Symptoms begin 6-12 hours after last use, peak at 36-72 hours, resolve over 7-10 days.

Long-acting opioids (methadone, buprenorphine): Symptoms begin 24-48 hours after last use, peak at 3-4 days, may persist 3-6 weeks.

Symptoms

• Intense anxiety and restlessness ("skin crawling")
• Severe insomnia
• Muscle aches and cramping
• Abdominal cramping, nausea, vomiting, diarrhea
• Sweating, chills, hot/cold flashes (origin of "cold turkey")
• Yawning, runny nose, teary eyes
• Elevated heart rate and blood pressure (not as dangerous as alcohol withdrawal)
• Dilated pupils
• Piloerection (goosebumps — origin of "cold turkey")

Not life-threatening in healthy adults, but:

• Severe dehydration from vomiting + diarrhea can be dangerous, particularly in elderly or compromised patients
• Patients in severe opioid withdrawal are at extremely high relapse risk — single relapse after period of abstinence can cause fatal overdose (tolerance has decreased significantly)

Field Management

Comfort measures:

• Ibuprofen: muscle aches, fever, general discomfort
• Loperamide (Imodium): diarrhea control. Also crosses the blood-brain barrier at high doses and provides mild opioid receptor effect. Standard anti-diarrheal doses are appropriate and helpful.
• Diphenhydramine (Benadryl): sleep support, mild anxiolytic
• Ondansetron (Zofran) or promethazine if available: nausea management
• Oral hydration/ORS: critical for replacing losses
• Clonidine 0.1mg TID: alpha-2 agonist that reduces the autonomic hyperactivity (sweating, elevated heart rate, anxiety) of opioid withdrawal. Requires blood pressure monitoring — can cause hypotension.

Buprenorphine (Suboxone/Subutex): If available, it is the standard of care for managing opioid withdrawal. It activates opioid receptors sufficiently to prevent withdrawal while having a ceiling effect on respiratory depression. Can be stored and used without refrigeration. Has dramatically changed opioid withdrawal management.

Methadone: Can substitute for opioids during withdrawal management. Requires careful dosing and monitoring due to variable half-life and overdose risk.

Benzodiazepine Withdrawal

Benzodiazepine withdrawal follows the same mechanism and similar risk profile as alcohol withdrawal. Critical difference: the half-life of many benzodiazepines is long (diazepam's active metabolites have a half-life of 20-100 hours), meaning withdrawal symptoms may be delayed 3-7 days after stopping long-acting benzodiazepines.

Management is the same as alcohol withdrawal: benzodiazepine taper (if possible, substitute a long-acting benzo like diazepam for shorter-acting agents like alprazolam/Xanax, then slowly taper the diazepam).

A slow taper over weeks to months is safer than abrupt discontinuation for high-dose, long-term benzodiazepine users.

Stimulant Withdrawal (Cocaine, Amphetamines)

Not life-threatening. Characterized by:

• Profound fatigue and hypersomnia
• Increased appetite
• Depression, anhedonia (inability to feel pleasure)
• Irritability

Management: rest, nutrition, time. The depression can be profound and increases suicide risk in susceptible individuals — monitor mental state carefully.

Cannabis Withdrawal

The existence of cannabis withdrawal syndrome is now well-established (included in DSM-5 since 2013). It is uncomfortable but not dangerous.

Symptoms: irritability, anxiety, insomnia, decreased appetite, restlessness, depressed mood. Onset 1-3 days after cessation, peak at 2-6 days, resolve within 2-3 weeks.

Management: symptomatic. CBN (cannabinol) or CBD products may help sleep without re-exposure to THC.